Search results

Ilonov develops first-in-class biotherapies unlocking the muscle secretome to counter metabolic dysfunction. Our lead assets, based on human-centric discovery, preserve mitochondrial health, maintain tissue function and reduce chronic inflammation, addressing the unmet need in diabetes and MASH.

Betta Scientific is a Life Sciences consultancy. We support start-ups and established companies in entering international markets. Our clients rely on us to design and execute global go-to-market strategies, build international distribution networks, and accelerate revenue generation across borders.

Alpinuity Bio aims to provide consulting services in the field of biopharmaceutical R&D specifically in translational science and biomarkers. We advise and support investors, start-ups and established companies in due diligence, scientific and technical aspects.  

Clinical development strategy and execution, without noise.

Accelsiors is a global, full-service clinical research organization delivering end-to-end trial solutions under one roof. For over 20 years, we’ve supported biopharma with scientific, regulatory, legal, and operational expertise, driving efficient, high-quality clinical development worldwide.

DKSH is a global distribution and strategic solutions partner for life science and industrial specialties. We provide innovative and sustainable pharmaceutical and biopharmaceutical ingredients to manufacturers across Asia, Europe, and North America.

Nucleus Network is a global early-phase clinical trial network supporting pharma and biotechs in Phase I and Ib development. We deliver FIH, SAD/MAD and PoC studies through integrated clinics in the UK (Hammersmith Medical Research), USA and Australia, with strong PK and translational expertise.

Real Chemistry is a global healthcare communications network accelerating the journey from molecule to market. We integrate deep scientific and medical expertise, advanced AI, data-driven strategy, and creative excellence to deliver evidence-based engagement and measurable commercial impact.

Hettich AG, based in Bäch, Switzerland, has supplied laboratory equipment since 1977. We develop and distribute Hettich instruments and represent Memmert, Helmer, B Medical Systems and delta T, supporting life science customers with expertise, reliability and local service.

RhyGaze is a cutting-edge biotechnology company based in Basel, Switzerland, and Philadelphia, Pa., USA, focused on developing gene therapies for retinal diseases causing blindness and aims to restore vision and transform the lives of patients worldwide.

We are a small CRO providing highly tailored services to customers with clinical trials and regulatory consulting needs. With expertise in drug, food supplements, medical devices, diagnostics and software, we support you at every stage of product's lifecycle, from preclinical development to market.

Headquartered in Switzerland with global operations, Space Peptides provides end-to-end pharmaceutical Peptide CRDMO services - covering discovery, process development, and GMP manufacturing. In addition, our portfolio comprises a broad range of generic Peptide APIs.

Pharmaron, founded in 2004, is a leading life sciences service provider offering research, development, and manufacturing across drug discovery and clinical development for small molecules, biologics, and CGT. With 22,000+ staff, it operates in China, the U.S., and the U.K.

Asemblis is a Swiss TechBio company developing scalable, human-relevant in vitro models for obesity and metabolic disorders. The company partners with industry and research organizations to support translational R&D and decision-making in drug development

Inventicia GmbH/LLC is a consulting firm based in Switzerland partnered with leading global consulting firms offering innovative solutions across IT, data and digital services to Swiss/ EU biopharma clients. We also support local representation of international biopharma in particular from India

AzureCell is a Swiss regenerative cell therapy company leveraging two decades of pioneering neuroscience and cell‑engineering research at the University of Geneva to advance next‑generation allogeneic cell‑replacement therapies for the brain.

Streamlining complexity: with 15+ years experience (EU, US and Far East) in Oncology, Rare Diseases and Quality of Life Assessment, Naexture provides ad-interim leadership roles in Clinical Operations and Program Management to end-to-end operationalize clinical research programs.

Stallergenes Greer is a fully integrated global healthcare company specialising in the research, diagnosis and treatment of allergies through the development and commercialisation of allergen immunotherapy (AIT) products and services.

Swiss Rockets is dedicated to developing groundbreaking medicines that transform the treatment of cancer, infectious diseases, and autoimmune disorders – advancing more effective, equitable, and accessible healthcare for patients worldwide.

CALDRE is a Switzerland based biotech spin-out focussed to revolutionize the way cholestatic-and fibrotic diseases are treated. We develop precise, liver-directed GalNAc-siRNAs to restore bile flow and prevent fibrosis - placing CALDRE in the fast-growing RNA-therapeutics segment of biotech.

RC TRITEC is an established company offering custom synthesis of tritium-labeled compounds, a range of tritiated catalog products, storage service and disposal of radiochemicals. We have over 60 years of experience in the safe handling of tritium gas using in-house developed high-vacuum equipment.

Almac provides the most comprehensive global clinical supply chain solution in the marketplace. Guided by our extensive supply experience, we provide the physical resources and supportive technologies that ensure your clinical supply chain continually delivers across the globe.

Macrogen Europe GmbH, Swiss branch of Macrogen Europe B.V. (Amsterdam), provides fast, reliable Sanger and NGS sequencing. All sequencing labs are based in Amsterdam and Seoul. We support research and clinical needs across Europe and Africa with advanced genomic and bioinformatics services.

Mirava Bio is a Swiss BioCommercial Partner enabling emerging biotechs to bring rare disease & gene therapies to Europe, the Middle East & Eurasia. We define optimal go-to-market strategies and execute via a plug-and-play licensed ready platform, minimizing risk while partners retain control.

We develop animal-based products via cell cultivation, combining proprietary animal cell biology with scalable bioprocessing at favorable unit economics. The platform starts with the world's first cultivated whole-cut beef and expands into functional applications, like cell-derived collagen.

SYDRA AG (Zurich) is a longevity biotech using a phenotype-first, AI-assisted “Hit-to-Target” early drug discovery platform. We discover small molecules (geroprotectors), validate in vivo (worms – aged mice), then map MoA to build partner-ready drug assets; plus science-backed supplements.

Topadur Pharma AG, founded in 2015 in Schlieren, is a clinical-stage biopharmaceutical company. Leveraging its proprietary DualTOP™ platform, Topadur develops dual-acting molecules that restore cGMP levels, repairing microcirculation, promoting tissue regeneration, and addressing oxygen deficiency.

Axcura AG is a Swiss life-science company specializing in the sourcing, qualification, and distribution of pharma and biotech raw materials. We combine Swiss quality, regulatory excellence, and global supplier networks to secure reliable, compliant supply chains.

Blanc-Labo has been installing and maintaining in Switzerland complex equipments for laboratories for the past 35 years. We have about 4000 customers in Switzerland and France: biotechs, universities, industries. We are based in Lonay near Lausanne.

Swiss Consultant-Network GmbH is developing a new data management system that can be used as a framework for the integration of heterogeneous data in the field of biological research and development. We offer our customers IT engineers, who have in-depth knowledge of computer science disciplines.

Jantar is a clinical R&D company in the field of chronic rhinosinusitis. Its product is a nasal spray of dicholine succinate. Clinical efficacy has been demonstrated by well-documented case studies which showed that the drug relieves all symptoms of the disease. A PCT patent has been filed.

Mabylon is a clinical-stage company leading innovation in human-derived antibody therapeutics for severe allergies, inflammation, and neurological disorders. MY006, our first-in-class multi-specific antibody therapeutic for peanut allergy, is tackling the growing food allergy market.

With 30 years' experience, ICARE stands out as a leader in international standardisation and regulation. We guide healthcare industry through the complex regulatory landscape, ensuring that every healthcare device and product is marketed in full compliance and safety.

GTP Bioways is a French-based CDMO that prioritizes customized services supporting biopharmaceutical companies throughout their journey from R&D to clinics. With more than 20 years’ experience, we specialize in process development and GMP manufacturing of biologics, bioconjugates and nanodrugs.

Enantios is a Swiss startup revolutionizing molecular characterization with in-solution structural analysis of chiral complex molecules and Antibody drug Conjugates (ADCs). Enantios delivers solutions for quality control and drug development in pharmaceutical, biotech, and chemical industries.

As a health company, we envision empowering global well-being by pioneering biological solutions drawn from nature. Our mission: Unlock the full potential of exDNA across diverse indications. Our AND Technology Platform has the primary focus on controlling disease caused by pathogenic bacteria.

steerBIO GmbH is a boutique management consultancy for the VC, biotech and pharmaceutical industry. We support your complex R&D challenges associated with modern drug development and medical launch by integrating deep knowledge, honest analysis and strategic thinking in a co-creative approach.

Our platform enables efficient, tunable multiplex gene silencing, modulating multiple targets in one construct for superior safety and potency over traditional editing. Its modular design suits various cell and gene engineering applications.

GMP4U is offering engineering and consulting services for the life sciences industry. As experts in qualification and validation, we support our clients in ensuring GMP compliance for production equipment, laboratory instruments, and information management systems.

CMC & More delivers hands-on CMC, regulatory, and quality expertise for biotech and pharma. We bridge discovery to first-in-human trials and beyond with GMP-compliant CMC strategies that derisk development and transform complex products into approval-ready assets.

At Lederer & Partner AG, we transform complex visions into clear successful results. Our expertise in engineering, construction, commissioning, qualification, and operation, we develop project models that are precisely aligned with your goals. As your trusted partner, we deliver lean, efficient solutions.

Ultimate Medicine is a Swiss preclinical biotech focused on preserving independence and quality of life for patients with Alzheimer's disease and other dementias.

EVIIVE develops single extracellular vesicle-based diagnostics to predict immunotherapy response and monitor tumor microenvironment in real time. Our platform integrates advanced flow analytics and machine learning for precision oncology applications.

TheraPPI Bioscience, a preclinical biotechnology company developing small molecules modifying protein interactions in oncology, rare diseases and inflammation

AVEctivate supports pharma, biotech and diagnostic companies aiming to make a positive difference to patients, and health care providers by offering strategic consulting, project management and interim management. Believing that change is the only constant, we embrace the future as an opportunity.

We want to be strategic collaborator with executive management and empower in-house IR/PR professionals to help you build lasting and mutually beneficial relationships with investors, partners, media, and other stakeholders.

Tridek-One is a biotech start-up developing first-in-class CD31 agonist modalities designed to restore the immune balance.

Jeffries IP stands out for delivering bespoke IP solutions tailored to each client's unique needs. My industry knowledge, legal expertise and understanding of commercial realities allow me to provide practical strategic advice to help clients unlock the value of their intellectual property.

SPILLO supports pharmaceutical and biotech R&D teams through unbiased, in silico, proteome-wide identification of targets and off-targets. Using exclusive, experimentally validated, physics-based computational technology, SPILLO reduces scientific risk and clarifies mechanisms in drug development.

Axxam S.p.A. is a CRO delivering integrated early drug discovery, from target identification to lead generation. Through its DiscoveryMAXX platform, it supports pharma, biotech, start-ups, and academia with biology-driven solutions across all therapeutic areas and target classes.

The grow Foundation provides small and large Life Sciences companies ready-to-use laboratories, offices, piloting and production facilities in Wädenswil/Horgen, in size ranging from a few working benches to several thousand m2.

Devintec Pharma is focused on B2B partnerships through out-licensing innovative substance-based medical devices. We apply DevinPro™ technology, that addresses root causes and creates a protective barrier for lasting relief, to our patended products in gastroenterology, dermatology, and gynecology.

A swiss-based company developing therapeutics for chronic inflammation. We are engineering novel bi-functional Duokine therapeutics, rationally designed to simultaneously target distinct immune cell populations and disease-relevant pathways.

Nxera Pharma is a tech-driven biopharma company focused on specialty medicines for unmet needs in Japan and globally. With 30+ active programs in neurology, GI, immunology, metabolic, and rare diseases, Nxera employs 350+ people across Japan, the UK, Switzerland, and South Korea.

Provides consulting services to pharma and biotech clients in market access and pricing area. Support geographic expansion strategies for Asian life sciences companies. Trading in nutraceuticals products for European markets.

TransHeps specializes in iDILI causality assessments, supporting drug developers in clinical trials and managing drug-induced liver injuries. Leveraging cutting-edge expertise, we provide reliable solutions to improve drug safety and accelerate pharmaceutical innovations.

WittKieffer is a top 10 executive search and leadership advisory firm exclusively specialised in life sciences organizations operating at the intersection of academia, science, and healthcare.

VivoArchitect is a preclinical Contract Research Organization (CRO) specialized in in vivo mouse models for longevity and age-associated diseases. We provide research services for biotech companies, covering experimental design, ethical approval, study execution, and scientific reporting.

metaLead is an early-stage life science spinout from the University of Zurich, supported by reputable investors, i.e., BaseLaunch. We aim to revolutionize the treatment landscape for metal-related diseases, starting with Wilson disease, leveraging our platform of novel, rationally designed peptides.

Leman Biotech is a clinical-stage biotech advancing immunotherapy via metabolic reprogramming. Its META 10 platform reverses T-cell exhaustion to unlock unprecedented efficacy and durability in oncology and autoimmune diseases, delivering a highly effective, scalable, and accessible approach.

INNOSIAMO - Where strategy meets healthcare innovation! We help our clients navigate providing actionable strategies driving innovation and operational excellence.

Philip Morris International (PMI) is a leading international tobacco company with the objective to replace cigarettes with smoke-free products. The goal is to offer adult smokers, who would otherwise continue to smoke, better alternatives that are scientifically substantiated.

Abbmira therapeutics is a Basel based biotech founded by experience scientists and entrepreneurs in September 2024. Abbmira develops first-in-class small molecules to fine-tune native immunity to treat difficult-to-treat cancers and chronic diseases.

We "think data" and "speak biology", partnering with our clients to transform lives. Our team combines deep biological knowledge with proven expertise in AI & bioinformatics to tackle complex data challenges. Via our AI-native Bio|Verse platform, we accelerate biomarker discovery & drug development.

ObelysQ is a leading consulting firm offering tailored solutions to the pharma industry aiming at enhancing compliance and improving processes in the execution of clinical trials. Our Headquarters are in Neuchâtel, with a branch in Poland.

At CxO, we drive biotech startups toward growth by optimizing resource management and operational efficiency. As partners, we empower firms to innovate and scale. Our veteran team offers strategic insights to accelerate timelines, optimize ROI, and enhance workflows, ensuring client success

InVirtuoLabs is pioneering the next-generation laboratory by integrating AI with molecular simulations to revolutionize drug discovery. Our platform generates up to 1 billion novel molecules per day, rapidly screening and identifying the most promising ligands for specific biological targets.

Avenza Consulting has been created to support pharma, biotech companies, startups to develop and grow by offering Strategic Consulting, R&D services to foster innovation, Program & Portfolio Management to optimize projects, and Operational Excellence to streamline processes.

Precise Health develops AI-powered platforms for bacteriophage discovery, host-matching, and engineering. We serve hospitals, biotech, and pharma in the $50B+ anti-infectives and diagnostics markets, addressing the urgent global threat of antimicrobial resistance

Juvion develops advanced therapeutics aimed at preserving neuron-muscle connectivity, tackling immobility and sarcopenia to extend healthspan.

We provide a portfolio of models for efficacy pharmacology in autoimmunity, immuno-oncology, and transplantation. Our humanized mouse and tumor xenograft platforms enable translational evaluation of biologics, cell therapies, and innovative immunotherapies.

Enzene is a fully integrated CIDMO with sites in Pune (India) & New Jersey (USA), offering discovery to commercial supply. Its EnzeneX™ FCCM™ tech leads next-gen biologics, aiming to cut mAb costs below $40/g by 2025. Learn more at www.enzene.com.

BeOne Medicines is a global oncology company developing innovative, affordable, and accessible cancer treatments worldwide. We expedite development of our diverse pipeline of novel therapeutics through strong internal capabilities and collaborations. Our 11,000 colleagues span six continents.

Justin Stindt Consultants is a consulting firm specializing in Strategy & Market Access advisory services for the pharmaceutical, biotech and medical device industries.

The Nikon Microscope Solutions unit is focused on serving customers in research, biotech/pharma, the clinical laboratory, and academia with industry leading microscope-based imaging solutions. In addtion the Nikon BioImaging Lab, is a CRO that provides microscope-based imaging and analysis services.

We are offering worldwide professional medical writing and related services to the pharmaceutical (human & veterinary), biotech, medical device and other industries, CROs and academic institutions. With over 20 years of experience in the field, we guarantee the best possible medical writing.

Founded in mid-2022, T-Oncology is a Swiss biotech startup dedicated to transforming cancer treatment through innovative therapies. Our Mission: Give hope to patients by creating advanced therapeutics that offer safe and more effective treatment options, affordable for patients worldwide.

Amporin is developing a new class of small molecule amyloid pore inhibitors as the first potential acute oral drugs to stop and reverse the progression of deadly degenerative diseases. Our vision is to cure 6 major degenerative diseases with a simple pill, starting with Parkinson’s disease.

Access2Health partners with biotechs, providing flexible, cost-effective support to maximise asset value. We offer strategic guidance in market potential, evidence generation, pricing, and value strategy, helping biotech leaders make informed decisions that strengthen their position with investors.

ICE Biopharma has 2 core businesses: in-licensing specialty and rare disease drugs for Europe and Canada, and operational consultancy to companies evaluating international Commercialization options. We want European and Canadian patients to have access to the breakthrough therapies they deserve.

ANSEA is a global consulting firm enabling pharmaceuticals, biopharmaceuticals and medical device companies navigate through the complexities of healthcare systems across the world and helping bring their solutions to patients.

Allegria Therapeutics was founded in Basel in 2023. Pursuing a differentiated portfolio of proprietary therapeutic approaches around biological targets that selectively modulate mast cells, Allegria plans to redefine the treatment landscape for allergy and mast cell-mediated inflammatory diseases.

Complyomics supports Life Sciences companies in core areas as: Build and maintain robust Quality Systems in compliance with regulatory requirements. Provide externalized QA. Audits Develop expertise in Bioanalytical / Analytical areas Identify / assess / supervise sub-contractors Due diligence

Tandem Therapeutics (Spin-off ETH Zurich & PSI) is tackling the growing unmet medical need in treating fibrosis with precision extracellular matrix targeting. Our novel peptide drug conjugates selectively target mechanical changes in the fibrotic extracellular matrix to potentially halt progression.

ENABLE Biotech aims to partner with companies from research to clinical stage to address specific challenges of manufacturing Advanced Therapies. Our next generation CDMO model enables an attractive pricing structure and expertise in CMC for speed to Phase I/IIa.

NanThermix SA is a pioneer in nanoscale temperature control within living cells for applications across life sciences, from academic research to biomedical fields, based on a novel technollogy of all-optical nanodiamond heater / thermometer.

HekeTiss, a UNIGE/HUG spin-off, enhances lives by pioneering cell-therapy treatments for ulcerative skin conditions. Innovating for a healthier tomorrow.

We build true longevity by turning proven drugs into patient-friendly, affordable prescription medicines. With our ORASMART® platform technology, we scale from an initial focus on two indications to more than 30 longevity therapies across metabolic diseases, chronic care, and beyond.

Apricot BIO is a first-time launcher of a Functional Precision Oncology platform performing deep molecular phenotyping of drug responses for personalised therapy recommendations for early to late-stage clinical decision-making leading to more precise, evidenced-based recommendations for doctors.

Luminance Health is a premium life science consultancy providing personalized support across the entire value chain. We provide cross-functional strategic and hands-on support to develop, register, market and bring innovative products to market.

Curie.Bio is a $1.2B VC founded to discover and develop important new medicines. We do that by investing directly into existing companies, creating focused spinouts, and helping founders build companies from scratch. Our team of >80 full-time drug hunters provides hands on support to founders.

DIAMANTE is a boutique business and management consulting company dedicated to biotech/ pharma clients, diagnostics companies and investors in healthcare. We support companies to streamline product design and development, and work with investors to accelerate and de-risk their selected assets.

At Stämm we develop accessible, plug & play biomanufacture solutions; allowing an automatized, continuous and more efficient production of biologics and cell therapies while managing media conditions. We have reinvented biomanufacturing by providing an alternative to the known biomass production.

At EY, we are proud to be driven by our purpose to build a better working world, helping to create long-term value for our clients, people, and communities. As a trusted partner, we leverage our experience, knowledge, and services around the world.

chAIron blends AI with deep life-science expertise to accelerate R&D. We identify and prioritize new indications, strengthen evidence, de-risk development decisions, and unlock the full potential of pharma and biotech assets—helping deliver better outcomes for patients.

Kellerhals Carrard's highly specialized and interdisciplinary Life Sciences team is one of the strongest in Switzerland. We advise biotech and pharma clients of all sizes from startups to large multinationals on their most prominent and complex matters, both in Switzerland and abroad.

At ATANIS Biotech AG, our mission is to revolutionize the way allergies are diagnosed and thereby to improve treatment success Our novel cell-based assay allows us to quantify patients allergic status with unparalleled diagnostic accuracy, without needing to expose patients to the culprit allergen.

We offer a integrated service model in the special areas of corporate transactions, international and local accounting & reporting as well as tax, from start-up to IPO or sale. We focus on M&A and CFO services including interim management.

Oryl Photonics has developed a groundbreaking laboratory instrument for solubility and aggregation measurement. It is the world's first accurate and rapid solubility testing solution that saves precious drug compounds.

MedScienceSwiss AG is developing the technology of the future for the treatment of resistant bacteria and has the potential to significantly reduce the number of deaths in hospitals due to nosocomial infections and save resources and money, payers & Nat. Health services. Visit our poster Nr 25 at the Swis

Bavarian Nordic is a fully integrated vaccine company focused on the development, manufacturing and commercialization of life-saving vaccines. Our manufacturing site for oral vaccines is located in Thörishaus, 15 km southwest of Bern.

iCure offers the Cardinal platform for developing digital health applications that comply with cybersecurity standards, with end-to-end encryption, FHIR interoperability, and open-source SDKs, accelerating innovation in e-health. iCure is ISO27001,ISO13485,HDS certified and GDPR and NIS2 compliant.

Altorfer Engineering is a specialized contractor and consulting company. We provide expertise in engineering and project management services, and technology transfers. Our focus is on developing and managing aseptic formulation and fill-finish processes tailored to your receiving sites.

Blueprint Medicines is a global precision therapy company inventing life-changing therapies for people with cancer and blood disorders. Applying an approach that is both precise and agile, our medicines selectively target genetic drivers, with the goal of staying one step ahead of disease.

Infinity Communications works with start-up and growth-stage healthcare companies to deliver insights-driven, strategic communications. We add value by developing content and material to raise your company profile, attract new investors and engage audience groups across the health ecosystem.

NegotiumBio supports pharmaceutical & biotech companies in executing outsourced manufacturing and also business development strategies across diverse modalities (small / large molecules, cell & gene therapies).

LabForce AG is a Swiss company, founded in January 1999. We have the largest portfolio of antibodies, proteins and assay kits in Switzerland accomplished by innovative and best in class laboratory equipment in the field of cellular and molecular biology.

inSEIT solves the challenges of enzyme immobilization and unlocks the potential of immobilized biocatalysts for the production of APIs and chemical intermediates. We use bioinformatic tools to reduce the risk, time and cost associated with biocatalyst development.

Akceso Advisors: specialist pricing, reimbursement & market access advisor firm. For your buy/sell side 'Evidence-based Asset Valuation' and payer-relevant input into your development plan design. Akceso Advisors: Catalysts to patient access and pricing success. For better public health worldwide.

Fortrea (formerly Labcorp Drug Development/ Covance) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We provide phase I-IV clinical trial management, clinical pharmacology, technology enabled trial solutions and post-approval services.

We at INCAPTEK are developing advanced drug delivery systems. We deliver drugs at the right place, in the right dosage, and at the right time. Our smart, programmed-shell micro(nano)capsules can be used for controlled and targeted drug delivery for both biotech and medtech.

Curare specializes in translational and clinical pharmacology, increasing confidence in therapeutics translation from the bench to clinical proof of concept, and enhancing early stage decision-making.Expertise tailored to your needs, from small biotech to pharma.

MRGN Advisors was established in 2015 to advise CEOs, boards and investors on portfolio strategy, commercial and market access development, partnering and investment advisory in pharma, biologicals, vaccines, med tech and healthcare IT. Our motto: Even monkeys fall from trees — Japanese Proverb

Our goal is to deliver innovations in health care through cutting-edge tech and research, addressing challenges in antimicrobial therapies to improve patient outcomes. We are committed to delivering superior treatments that promote healing and improve quality of life globally.

Since 2014, Otten Life Sciences Consulting offers company services in finance or health care industries including: Buy-side due diligence for investors – Advisory practices for companies and investors – C-suite assignments for companies and investors

Watson-Marlow is a specialist manufacturer of pumps and tubing, fluid path components and single-use technology for GMP regulated industries. A portfolio of products and assembly design capabilities allows WMFTS to provid accuracy, reliability, and sterility in all fluid handling applications.

IPS-Integrated Project Services, a Berkshire Hathaway company, is a global leader in developing innovative solutions for the consulting, architecture, engineering, project controls, procurement, construction management, and CQV of technically complex facilities in the life sciences industry.

I work WITH my clients as a freelance science business development project manager. Having said that, Boehler Life Science Advice is not typical consultancy, even though strategic planning and execution is an important part of supporting my clients.